Literature DB >> 33692757

Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements.

Carmel Braverman-Gross1, Nissim Benvenisty1.   

Abstract

Maturity onset diabetes of the young (MODY), is a group of monogenic diabetes disorders. Rodent models for MODY do not fully recapitulate the human phenotypes, calling for models generated in human cells. Human pluripotent stem cells (hPSCs), capable of differentiation towards pancreatic cells, possess a great opportunity to model MODY disorders in vitro. Here, we review the models for MODY diseases in hPSCs to date and the molecular lessons learnt from them. We also discuss the limitations and challenges that these types of models are still facing.
Copyright © 2021 Braverman-Gross and Benvenisty.

Entities:  

Keywords:  disease modeling; genetic and epigenetic aberrations; human embryonic stem cells; induced pluripotent stem cells; maturity onset diabetes of the young

Mesh:

Year:  2021        PMID: 33692757      PMCID: PMC7937923          DOI: 10.3389/fendo.2021.622940

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  67 in total

1.  Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.

Authors:  Holger A Russ; Audrey V Parent; Jennifer J Ringler; Thomas G Hennings; Gopika G Nair; Mayya Shveygert; Tingxia Guo; Sapna Puri; Leena Haataja; Vincenzo Cirulli; Robert Blelloch; Greg L Szot; Peter Arvan; Matthias Hebrok
Journal:  EMBO J       Date:  2015-04-23       Impact factor: 11.598

Review 2.  Genetic and epigenetic stability of human pluripotent stem cells.

Authors:  Riikka J Lund; Elisa Närvä; Riitta Lahesmaa
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

3.  Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells.

Authors:  Gopika G Nair; Jennifer S Liu; Holger A Russ; Stella Tran; Michael S Saxton; Richard Chen; Charity Juang; Mei-Lan Li; Vinh Q Nguyen; Simone Giacometti; Sapna Puri; Yuan Xing; Yong Wang; Gregory L Szot; Jose Oberholzer; Anil Bhushan; Matthias Hebrok
Journal:  Nat Cell Biol       Date:  2019-02-01       Impact factor: 28.824

4.  The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.

Authors:  M Stoffel; S A Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 5.  CRISPR technologies for stem cell engineering and regenerative medicine.

Authors:  Mu-Nung Hsu; Yu-Han Chang; Vu Anh Truong; Po-Liang Lai; Thị Kieu Nuong Nguyen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2019-09-09       Impact factor: 14.227

Review 6.  Causes and effects of haploinsufficiency.

Authors:  Adam F Johnson; Ha T Nguyen; Reiner A Veitia
Journal:  Biol Rev Camb Philos Soc       Date:  2019-05-31

Review 7.  From Genetic Association to Molecular Mechanisms for Islet-cell Dysfunction in Type 2 Diabetes.

Authors:  Katia K Mattis; Anna L Gloyn
Journal:  J Mol Biol       Date:  2020-01-13       Impact factor: 5.469

Review 8.  Quality control: Genome maintenance in pluripotent stem cells.

Authors:  Uri Weissbein; Nissim Benvenisty; Uri Ben-David
Journal:  J Cell Biol       Date:  2014-01-20       Impact factor: 10.539

Review 9.  Concise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic β-Cell Pathology.

Authors:  Diego Balboa; Jonna Saarimäki-Vire; Timo Otonkoski
Journal:  Stem Cells       Date:  2018-12-02       Impact factor: 6.277

Review 10.  Genetics of Monogenic Diabetes: Present Clinical Challenges.

Authors:  Shivani Misra; Katharine R Owen
Journal:  Curr Diab Rep       Date:  2018-10-30       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.